Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

REGENERON PHARMACEUTICALS, INC.

Pharmaceutical Preparations | SIC: 2834
Phone: 9148477000

CIK: 0000872589
EIN: 133444607
State Location: NY
State of Inc.: NY

Nasdaq:REGN

Form: 4

Filing Date: 23 Feb 2026
Report Date: 19 Feb 2026
Accepted: 23 Feb 2026 02:55 p.m.
Accession Number: 0001681643-26-000004

Act: None
File Number: None
Film Number: None

Documents

Primary Document: PRIMARY DOCUMENT

Accepted: 23 Feb 2026 02:55 p.m.

0001681643-26-000004-index-headers.html

Last Modified: 23 Feb 2026 02:55 p.m.

0001681643-26-000004-index.html

Last Modified: 23 Feb 2026 02:55 p.m.

0001681643-26-000004.txt

Last Modified: 23 Feb 2026 02:55 p.m.

Last Modified: 23 Feb 2026 02:55 p.m.